Challenging Nuclear Cardiology Research: Stimulating Discovery, Validation, and Clinical Relevance

Challenging Nuclear Cardiology Research: Stimulating Discovery, Validation, and Clinical Relevance.

Nuclear cardiology in Iran in 2002 [Persian]

Aim: Few nuclear cardiology surveys were published in the literature, mostly from developed countries. The aim of this study is to perform a nuclear cardiology survey in Iran. This may lead to better decision making and programming. Methods and Materials: A questionnaire was sent by mail or e-mail to all nuclear medicine centers in Iran asking for details of nuclear cardiology practice in...

The frontiers of nuclear cardiology research

Heart disease is the leading cause of death. Each year in the United States, more than 500,000 men and women die from coronary artery disease (CAD). CAD results from the narrowing of blood vessels that supply the heart. The blood vessels become narrow when fatty deposits build up inside the arterial wall. When the arteries become clogged, the blood flow to the myocardium is impaired and a heart...

Ischemic cardiomyopathy: a clinical nuclear cardiology perspective.

Ischemic cardiomyopathy results from severe extensive coronary artery disease, which is associated with left ventricular dysfunction and also, in many cases, with significant left ventricular dilatation. Mortality is high, especially in patients who satisfy myocardial viability criteria but who have not undergone revascularization. Although age, exercise capacity and comorbidity influence survi...

Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance

Graves' disease is the most common cause of thyrotoxicosis in women of childbearing age. Approximately 1% of pregnant women been treated before, or are being treated during pregnancy for Graves' hyperthyroidism. In pregnancy, as in not pregnant state, thyroid-stimulating hormone (TSH) receptor (TSHR) antibodies (TRAbs) are the pathogenetic hallmark of Graves' disease. TRAbs are heterogeneous fo...